Theravance, Inc. (THRX) and Astellas Pharma Inc. Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
11/6/2009 11:05:14 AM
More...
|
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) (JOBS) Commence Phase III Horizon Program to Develop a Next-Generation Treatment for COPD
10/27/2009 6:29:21 AM
More...
|
Theravance, Inc. (THRX) (JOBS) Earns $20 Million Milestone Under Telavancin Collaboration Agreement
10/23/2009 7:05:11 AM
More...
|
Theravance, Inc. (THRX) to Report Third Quarter 2009 Financial Results on October 27, 2009
10/20/2009 10:59:31 AM
More...
|
Theravance, Inc. (THRX) Announces New Employment Inducement Award
10/2/2009 8:58:09 AM
More...
|
Astellas Pharma Canada, Inc. (JOBS) and Theravance, Inc. (THRX) (JOBS) Announce Approval of VIBATIV(TM) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
10/1/2009 6:33:49 AM
More...
|
Theravance, Inc. (THRX) (JOBS) and Astellas Pharma Inc. (JOBS) Announce FDA Approval of VIBATIV(TM) for the Treatment of Complicated Skin and Skin Structure Infections
9/14/2009 7:09:17 AM
More...
|
Theravance, Inc. (THRX) to Present at Investor Conferences in September 2009
9/3/2009 12:20:46 PM
More...
|
Theravance, Inc. (THRX) Announces New Employment Inducement Awards
9/2/2009 11:34:16 AM
More...
|
Theravance, Inc. (THRX) Announces New Employment Inducement Awards
8/4/2009 10:50:15 AM
More...
|
|